SubHero Banner
Text

December 2021

Core topics in this month’s edition include:

  • Apretude (cabotegravir) - new drug approval
  • Rezvoglar (insulin glargine-aglr) - new biosimilar approval
  • Molunupiravir - emergency use authorization
  • Paxlovid (nirmatrelvir/ritonavir) - emergency use authorization

  • Download PDF

Text